Vice President and Head of Research Biology & Translational Medicine
Cue Biopharma
Boston, Massachusetts, United States
Steven Quayle is Vice President and Head of Research Biology & Translational Medicine at Cue Biopharma. Cue develops therapeutic fusion proteins to regulate immune responses in cancer and autoimmune diseases. Prior to joining Cue Biopharma, he held roles of increasing responsibility at Acetylon Pharmaceuticals, where he contributed to the development of selective histone deacetylase inhibitors. Before transitioning to Industry, he received his Ph.D. from the University of British Columbia in Canada and performed postdoctoral studies at the Dana-Farber Cancer Institute in Boston.
Disclosure information not submitted.
Wednesday, June 21, 2023
4:45 PM - 5:00 PM
